← Back to all trials
Not Yet Recruiting
NCT07700472
Endoscopic Ultrasound-Guided Ethanol Ablation for Aldosterone-Producing Adenoma
Conditions: Primary Aldosteronism, Aldosterone-Producing Adenoma
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 30
Sponsor: Chongqing Medical University
Location: The First Affiliated Hospital of Chongqing Medical University Chongqing Choongqing
Summary
This is a prospective, single-center, single-arm study evaluating endoscopic ultrasound-guided ethanol ablation for left-sided aldosterone-producing adenoma. Eligible participants will receive the ablation procedure and be followed for safety, imaging response, biochemical remission, and clinical remission. The study is expected to enroll 30 participants.
Eligibility Criteria
Inclusion Criteria:
1. Diagnosis of left-sided aldosterone-producing adrenal adenoma.
2. Unwillingness to undergo adrenalectomy or presence of contraindications to surgery.
3. Ability and willingness to provide written informed consent.
Exclusion Criteria:
1. History of alcohol allergy.
2. Inability to discontinue beta-blockers.
3. Inability to discontinue anticoagulants, antiplatelet agents, or glucocorticoids.
4. Platelet count \
Source: ClinicalTrials.gov (NCT07700472). StuddyBuddy aggregates publicly available trial information.
